Loading
II
Immunomedics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Avoro Capital Advisors LLC, was filed 01 May 2020.
Immunomedics Inc: what insiders have been doing
Immunomedics Inc is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Immunomedics Inc in twelve months, the latest record being from 23 October 2020.
The full history, which starts in 2016, counts 20 purchases against 48 sales.
In the same market, recent insider purchases at GameStop Corp. and Xenon Pharmaceuticals Inc. also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
161
Thresholds
n/a
Buy Volume
€164M
20 ops. · all time
Sell Volume
€8M
48 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$263k
Net income-US$318.4M-121081.4% margin
Last declaration on 23 October 2020
Declarations161 total
13,516 sharesCommon StockSEC:0001104659-20-117806:0
26,250,000 sharesCommon StockSEC:0001104659-20-117806:1
10,000 sharesCommon StockSEC:0001104659-20-117796:0
9,667 sharesCommon StockSEC:0001104659-20-117793:0
13,516 sharesCommon StockSEC:0001104659-20-117803:0
49,244 sharesCommon StockSEC:0001104659-20-117792:0
13,516 sharesCommon StockSEC:0001104659-20-117801:0
13,516 sharesCommon StockSEC:0001104659-20-117797:0
15,000 sharesCommon StockSEC:0001104659-20-117800:0
18,856 sharesCommon StockSEC:0001104659-20-117805:0
2,500 shares@ US$16.967.0% of flowCommon Stock, $0.01 par value per shareSEC:0001104659-20-105255:0
20,000 shares@ US$16.9656.2% of flowCommon Stock, $0.01 par value per shareSEC:0001104659-20-097230:0
17,077 shares@ US$12.9336.8% of flowCommon Stock, $0.01 par value per shareSEC:0001104659-20-095587:0
3,718 shares0Common Stock, $0.01 par value per share (''Common Stock'')SEC:0001104659-20-075724:0
3,718 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-075693:0
3,718 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-075692:0
3,718 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-075694:0
3,718 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-075697:0
3,718 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-075696:0
3,718 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-075695:0
1,750,000 shares@ US$28.5047.6% of flowCommon Stock, $0.01 par value per shareSEC:0000902664-20-001946:0
Canonical exit: 30 Jul 2020 (T+90)
50,075 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-048727:0
100,000 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-037009:0
2,000,000 shares@ US$17.5023.5% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0000902664-19-004538:0
Canonical exit: 4 Mar 2020 (T+90)
1,000,000 shares@ US$13.239.0% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0000902664-19-003903:0
Canonical exit: 31 Dec 2019 (T+90)
25 of 161 declarations
About Immunomedics Inc
Immunomedics Inc is a biopharmaceutical company focused on developing targeted therapies for cancer treatment. It is listed on the NASDAQ.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
